Our History

CraniUS began in May 2021 in Baltimore, MD

CraniUS was developed as a byproduct of the emerging field known as “Neuroplastic and Reconstructive Surgery”, through the vision, insight, and pioneering work of Dr. Chad Gordon. Our flagship device, known as the NeuroPASS, is being specifically developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional therapeutic treatments of brain disease ineffective. CraniUS utilizes a novel pump design and wireless charging technology to enable long-term and direct medicine administration via CED (convection-enhanced delivery), an effective method of medicine delivery first introduced by the National Institute of Health (NIH).

Our Technology

NeuroPASS Drug Delivery

A smart, refillable, and fully embedded medical device that effectively bypasses the blood-brain barrier and achieves long-term, convection-enhanced medicine delivery.

  • Direct access to the brain to achieve successful convection
  • Safe alternative to systemic drug delivery for brain disease
  • Easy access for refilling

Meet our team

Forward-thinkers driving patient and user-focused innovation

By bringing diverse skills together, we advance the output and quality of CraniUS.

Dr. Chad Gordon

Co-Founder, CMO

Mike Maglin

CEO

Jack Kent

VP, Strategy & Operations

Our Solution

The first fully implantable, wireless medical device that enables chronic and direct delivery of medicine to the brain.

Direct Custom Drug Delivery From the Skull Space Along the Temporal Region
Smart implant With Continuous Patient Monitoring
Power System with Wireless Charging
Easily Refillable